Pharmacokinetics of tacrolimus immediately after liver transplantation

Transplantationsmedizin: Organ der Deutschen Transplantationsgesellschaft

Volumn 16, Issue 2, 2004, Pages 112-116

  Tolou Ghamari, Zahra ^a   Palizban, A A ^a   Wendon, J ^b   Tredger, J M ^b  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b KING S COLLEGE HOSPITAL   (United Kingdom)

Author keywords

Liver transplantation; Pharmacokinetic variability; Tacrolimus; Transplant indication

Indexed keywords

TACROLIMUS;

ADOLESCENT; ADULT; AREA UNDER THE CURVE; ARTICLE; CHRONIC LIVER DISEASE; COMPARTMENT MODEL; CONTROLLED STUDY; DISTRIBUTION VOLUME; DRUG ABSORPTION; DRUG ACCUMULATION; DRUG BLOOD LEVEL; DRUG ELIMINATION; DRUG HALF LIFE; FEMALE; HUMAN; LIVER FAILURE; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MICROPARTICLE ENZYME IMMUNOASSAY;

EID: 4344702255     PISSN: 09469648     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Venkataramanan R, Jain A, Warty VW, Abu-Elmagd K, Furakawa H, Imventarza O, Fung J, Todo S, Starzl TE (1991) Pharmacokinetics of FK506 following oral administration: a comparison of FK506 and cyclosporin. Transplantation Proceedings 23: 931-3
2. Gruber SA, Hewitt JM, Sorenson AL, Barber DL, Bowers L, Rynders G, Arrazola L, Matas AJ, Rosenberg ME, Canafax DM (1994) Pharmacokinetics of FK506 after intravenous and oral administration in patients awaiting renal transplantation. Journal of Clinical Pharmacology 34: 859-64
3. Osowski CL, Dix SP, Lin LS, Mullins RE, Geller RB, Wingard JR (1996) Evaluation of the drug interaction between intravenous high-dose fluconazole and cyclosporin or tacrolimus in bone marrow transplant patients. Transplantation 61: 268-72
4. Boswell GW, Bekersky G, Fay J, Wingard J, Antin J, Weisdorf D, Maher R, Fitzsimmons W, Nash R (1998) Tacrolimus pharmacokinetic in bone marrow transplant patients. Bone Marrow Transplantation 21: 23-8
5. Jusko WJ, Piekoszewski W, Klintmalm GB, Shaefer MS, Hebert MF, Piergies AA, Lee CC, Schechter P, Mekki QA (1995) Pharmacokinetics of tacrolimus in liver transplant patients. Clinical Pharmacology and Therapeutics 57: 281-90
6. Undre N, Meiser BM, Uberfuhr P, Reichart B, Stevenson P, Schafer A, Moller A (1998) Pharmacokinetics of tacrolimus (FK506) in primary orthotopic heart transplant patients. Transplantation Proceedings 30: 1112-5
7. Fujisawa Ltd. Prograf (1997) Clinical pharmacokinetics of tacrolimus. Munich, Germany
8. Gonschior AK, Christians U, Braun F, Winkler M, Linck A, Baumann J, Sewing KF (1994) Measurement of blood concentrations of FK506 (tacrolimus) and its metabolites in seven liver graft patients after the first dose by HPLC-MS and microparticle enzyme immunoassay (MEIA). British Journal of Clinical Pharmacology 38: 567-71
9. Johnston A, Woollard RC (1983) STRIPE: an interactive computer program for the analysis of drug pharmacokinetics. Journal of Pharmacology Methods 9: 193-199
10. Cadoff EM, Venkataramanan R, Krajack A, Jain AS, Fung JJ, Todo S, Starzl TE (1990) Assay of FK506 in plasma. Transplantation Proceedings 22: 50-1
11. Staatz CE, Willis C, Taylor PJ, Lynch SV, Tett SE (2003) Toward better outcomes with tacrolimus therapy: Population pharmacokinetics and individualized dosage prediction in adult liver transplantation. Liver Transplantation 9 (2): 130-7
12. Christians U, Braun F, Winkler M, Linck A, Baumann J, Sewing KF (1994) Measurement of blood concentrations of FK506 (tacrolimus) and its metabolites in seven liver graft patients after the first dose by HPLC-MS and microparticle enzyme immunoassay (MEIA). British Journal of Clinical Pharmacology 38: 567-71
13. Tredger JM (1995) Using cyclosporin Neoral immediately after liver transplantation. United Kingdom Neoral Pilot Study Group. Therapeutic Drug Monitoring 17: 638-41
14. Gabe S M, Bjarnason I, Tolou-Ghamari Z, Tredger JM, Johnson PG, Barclay GR, Williams R, Silk DB (1998) The effect of tacrolimus (FK506) on intestinal barrier function and cellular energy production in humans. Gastroenterology 115: 67-74
15. Meerman L, Zijlstra JG, Schweizer J J, Verwer R, Slooff M J, Haagsma EB (1997) Acute liver failure: spontaneous recovery or transplantation? Scand J Gastro Suppl 223: 55-9
16. Lampen A, Christians U, Guengerich FP, Watkins PB, Kolars JC, Bader A, Gonschior AK, Dralle H, Hackbarth I, Sewing KF (1995) Metabolism of the immunosuppressant tacrolimus in the small intestine: cytochrome P450, drug interactions, and interindividual variability. Drug Metabolism and Dispositions 23: 1315-24
17. Shimomura M, Masuda S, Saito H, Sakamoto S, Uemoto S, Tanaka K, Inui K (2002) Roles of the jejunum and ileum in the first-pass effect as absorptive barriers for orally administered tacrolimus. Journal of Surgery Research 103 (2): 0215-22
18. Macphee IAM, Fredericks S, Tai T, Syrris P, Carter ND, Johnston A, Goldberg L, Holt DW (2002) Tacrolimus pharmacogenetics: polymorphisms associated with expression of cytochrome P450 3A5 and p-glycoprotein correlate with dose requirement. Transplantation 74: 1486-1489